{"id":137778,"date":"2014-08-31T16:50:10","date_gmt":"2014-08-31T20:50:10","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/who-will-pay-for-proactive-medicine.php"},"modified":"2014-08-31T16:50:10","modified_gmt":"2014-08-31T20:50:10","slug":"who-will-pay-for-proactive-medicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/who-will-pay-for-proactive-medicine.php","title":{"rendered":"Who Will Pay For Proactive Medicine?"},"content":{"rendered":"<p><p>    Last week I posted about the     huge, neglected value of proactive medicine. Afterwards I    talked with Bret Jorgensen, Executive Chairman of MDVIP, the    pioneer Concierge Medicine company. We talked about the results    that different intensive primary care models are demonstrating,    and the challenges they face when they attempt to convince    payers to invest resources in proactive medicine in order to    enjoy those benefits.  <\/p>\n<p>    Proactive Medicine refers to medical services that focus    heavily on engaging patients while they are healthy or early in    the disease process, developing strong relationships, and    providing early treatment or driving behavior change that    prevents or delays serious illness. Intensive primary care,    often called Concierge Medicine or Direct Primary Care, has    emerged recently as one of the most effective forms of    Proactive Medicine. Entrepreneurs\/start-up    companies have led the way here: MDVIP, Iora, OneMedical, among others. (1)  <\/p>\n<p>    Intensive primary care is important because 1) primary care    impacts almost 100% of the population and 2) the benefits are    big. Jorgensen reports that MDVIP has seen reductions of 80%    plus in ER and hospital utilization and in hospital    readmissions among a large group of Medicare patients that    benefit from MDVIPs particularly intensive primary care    service. This generated ~$300 millions of savings; most of the    savings benefitted the Medicare program. More important, it    improves the health    status and quality of life of patients.  <\/p>\n<p>    But [always a but], to implement intensive primary care    someone needs to spend more money up front. Health insurance    plans typically budget $25-$30 per member per month (PMPM) for    primary care. Intensive primary care costs at least $65 PMPM.    Total Total    U.S. healthcare spending is about $700 per person per month.    Spending $35 more on primary care pays off if the other $670    can be cut by 5%. Data that I have seen, both published and    unpublished, indicates that intensive primary care saves    10%-20% of total health care cost (e.g.:     1,     2). At national scale, that opportunity adds up to    $300-$600 billion. In addition there is the economic benefit of    a healthier, more-productive population, and the social benefit    of longer, healthier lives.  <\/p>\n<p>    The bottom-line question is: who will pay for the up-front    investment in primary care? In the beginning it was the    patients themselves. MDVIP has 220,000 members in 41 states who    pay about $135 PMPM on top of their health insurance, mainly    from personal funds.High-end self-insured employers are    starting to invest in intensive primary care. OneMedical has    successfully sold its moderately-priced Concierge Medicine    service to a number of employers, particularly silicon valley    companies that compete aggressively for talent and regard    benefits as a way to attract employees and keep them productive    and happy. Comcast    Comcast is investing in    Direct Primary Care for its employees.  <\/p>\n<p>    Mainstream commercial health plans and government payers, which    together spend at least 2\/3 of U.S. health care dollars, have    not embraced intensive primary care significantly, however.    Inertia and an awkward tax issue are factors. Beyond that,    however, government and large insurers seem to be locked into    the old-fashioned purchasing agent view of cost reduction: put    the squeeze on every vendor every day. That approach produces    short term results, but it does not capture the bigger savings    that a systems view of healthcare would enable: by spending    more on intensive primary care, payers can achieve a much    larger savings in the cost of advanced medical care.  <\/p>\n<p>    Another common objection goes: Primary care doctors are in    short supply, so its impossible to provide more-intensive    primary care. Thats a short-sighted argument. In the near    term, capacity can be expanded by increasing the numbers of    nurse practitioners and physicians assistants, and by    exploiting the large, untapped potential of telemedicine in    primary care. In the longer term increasing investment in    primary care and its status will increase the supply of MDs,    both from medical school and closely-related specialties.  <\/p>\n<p>    Heres how we can accelerate enjoying the benefits of    more-intensive primary care. Intensive primary care providers    need to keep producing outstanding results, and they need to    document those results with studies that are accepted by    peer-reviewed journals and insurance actuaries. This is    happening. Payers need to pull back a bit from their huge    immediate challenges and take a longer term, system view of how    to get more bang from the healthcare buck (2). It cant happen    soon enough.  <\/p>\n<p>    ================  <\/p>\n<p>    Notes:  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>View post:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.forbes.com\/sites\/toddhixon\/2014\/08\/29\/who-will-pay-for-proactive-medicine\" title=\"Who Will Pay For Proactive Medicine?\">Who Will Pay For Proactive Medicine?<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Last week I posted about the huge, neglected value of proactive medicine.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/who-will-pay-for-proactive-medicine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-137778","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/137778"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=137778"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/137778\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=137778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=137778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=137778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}